@article{rossum_kok_werkhoven_opdam_mandjes_stok_tinteren_imholz_portielje_bos_et al._2018, title={Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)}, volume={102}, DOI={10.1016/j.ejca.2018.07.013}, publisher={Elsevier BV}, author={Rossum and Kok and Werkhoven and Opdam and Mandjes and Stok and Tinteren and Imholz and Portielje and Bos and et al.}, year={2018} }